Trials / Recruiting
RecruitingNCT07004972
A Study of Mavacamten in Adults With Obstructive Hypertrophic Cardiomyopathy in India (ROVER)
A Phase 4, Single-Arm, Open-Label Study to Evaluate Safety, Tolerability, and Efficacy of Mavacamten in Adults With Symptomatic Obstructive Hypertrophic Cardiomyopathy in India
- Status
- Recruiting
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 50 (estimated)
- Sponsor
- Bristol-Myers Squibb · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate the safety, tolerability and effectiveness of mavacamten in adults with obstructive hypertrophic cardiomyopathy in India.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Mavacamten | Specified dose on specified days |
Timeline
- Start date
- 2025-09-04
- Primary completion
- 2027-12-13
- Completion
- 2027-12-13
- First posted
- 2025-06-04
- Last updated
- 2026-03-04
Locations
31 sites across 1 country: India
Source: ClinicalTrials.gov record NCT07004972. Inclusion in this directory is not an endorsement.